I

Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)Pharmaceutical Manufacturing · 5001-10000 · B2B contacts & data

15 Decision makers
10,000 Employees
2000 Founded

Decision Makers at Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)

Total identified

15 decision makers identified 4 C-Level 2 VP 9 Heads
Preview available contacts
Decision maker Email Phone

Create a free Zeliq account to access their verified emails and direct phone numbers.

See 15 decision makers on Zeliq →

Organizational Chart of Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)

Roles identified within Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)'s leadership team, based on public professional data.

Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)'s Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Team Structure headcount by department

Sales
9
General Management
3
Education
2
Finance
2
Medical
2
Operations
2
Other
2
Project Management
2

Funding

Last round Debt financing · $65M
Total funding $65M (1 round)
Debt Financing $65M Sep 2008

Companies similar to Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)

About Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)

Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) operates in the Pharmaceutical Manufacturing industry, based in United States. Founded in 2000, the company employs approximately 10,000 people. Within the wider Manufacturing sector, Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) focuses on the Pharmaceutical Manufacturing segment. Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) sells primarily to other businesses (B2B) rather than to end consumers. To date, Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) has completed 1 funding round totalling $65M. The data below (industry, headcount, location and business signals) helps sales teams qualify Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) and pinpoint the right decision makers from the first touchpoint.

Activity & Market

The company evolves in the Pharmaceutical Manufacturing segment of the Manufacturing sector. As a B2B company, Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) primarily serves business clients and professional organisations. The company is categorised as “Public company”.

How to prospect Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)'s departments

Sales

This is where the company's largest headcount sits (9 people). Talk numbers (conversion, cycle length, pipeline coverage) and you will get their attention quickly.

General Management

The company's second-largest department (3 people). General management thinks in strategic priorities: link your value proposition to one of theirs or you will not get a reply.

Education

2 people work in this department. Upskilling programmes take time to build: position yourself as a way to accelerate or measure them.

Finance

A team of 2 people. Timing matters here: approach them around budget planning cycles, when arbitrations are actually open.

Medical

This department counts 2 people. Medical teams trust peer references: name comparable organisations you already serve.

Operations

2 people work in this department. Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.

FAQ Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)

What industry does Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) operate in?

Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) is active in the Pharmaceutical Manufacturing industry, specifically in the Manufacturing category.

How many employees does Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) have?

Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) has approximately 10,000 employees (in the 5001-10000 range). This figure is an estimate to help qualify the account, not a legally certified number.

How do I find contacts at Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)?

With Zeliq, you can find the right decision makers at Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant), get their verified emails and direct phone numbers, and engage them through targeted multichannel sequences.

Where is Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) headquartered?

Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant) is headquartered in United States.

What is the organizational chart of Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)?

Based on public professional data, Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)'s organizational chart includes roles such as CEO, Executive, VP Clinical Research and Medical Affairs, President, Director, Sales Director. Zeliq lets you find the verified contact details behind each of these roles.

Why use this data before prospecting Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)?

With Ista Pharmaceuticals (Products Now Under Bausch + Lomb, Which Was Acquired By Valeant)'s firmographics and business signals at hand, you can prioritise the account, personalise your approach, and contact the right people straight away.